Related Experiment Video
Updated: Feb 14, 2026

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
Paolo Magistri1, Cecilia Battistelli2, Raffaele Strippoli2
1Department of Medical and Surgical Sciences and Translational Medicine, Sapienza-University of Rome, Rome, Italy.
Abstract:
HIGHLIGHTS Preliminary results of this work were presented at the 2016 Academic Surgical Congress, Jacksonville (FL), February 2-4 2016 (Original title: Selective Smo-Inhibition Interferes With Cellular Energetic Metabolism In Colorectal Cancer)This study was funded by "Sapienza-University of Rome" (Funds for young researchers) and "AIRC" (Italian Association for Cancer Research)Hedgehog inhibitor was kindly provided by Genentech, Inc.®. Colon Cancer (CC) is the fourth most frequently diagnosed tumor and the second leading cause of death in the USA. Abnormalities of Hedgehog pathway have been demonstrated in several types of human cancers, however the role of Hedgehog (Hh) in CC remain controversial. In this study, we analyzed the association between increased mRNA expression of GLI1 and GLI2, two Hh target genes, and CC survival and recurrence by gene expression microarray from a cohort of 382 CC patients. We found that patients with increased expression of GLI1 showed a statistically significant reduction in survival. In order to demonstrate a causal role of Hh pathway activation in the pathogenesis of CC, we treated HCT 116, SW480 and SW620 CC cells lines with GDC-0449, a pharmacological inhibitor of Smoothened (SMO). Treatment with GDC-0449 markedly reduced expression of Hh target genes GLI1, PTCH1, HIP1, MUC5AC, thus indicating that this pathway is constitutively active in CC cell lines. Moreover, GDC-0449 partially reduced cell proliferation, which was associated with upregulation of p21 and downregulation of CycD1. Finally, treatment with the same drug reduced migration and three-dimensional invasion, which were associated with downregulation of Snail1, the EMT master gene, and with induction of the epithelial markers Cytokeratin-18 and E-cadherin. These results were confirmed by SMO genetic silencing. Notably, treatment with 5E1, a Sonic Hedgehog-specific mAb, markedly reduced the expression of Hedgehog target genes, as well as inhibited cell proliferation and mediated reversion toward an epithelial phenotype. This suggests the existence of a Hedgehog autocrine signaling loop affecting cell plasticity and fostering cell proliferation and migration/invasion in CC cell lines. These discoveries encourage future investigations to better characterize the role of Hedgehog in cellular plasticity and invasion during the different steps of CC pathogenesis.
Insights
In colorectal cancer (CC), increased expression of the Hedgehog pathway gene GLI1 correlates with reduced survival. Inhibiting Smoothened (SMO) with GDC-0449 suppressed CC cell proliferation, migration, and invasion, suggesting SMO as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CC) is a leading cause of cancer-related death globally.
- The role of the Hedgehog (Hh) signaling pathway in CC pathogenesis is not fully understood.
- Aberrant Hh pathway activation is implicated in various human malignancies.
Purpose of the Study:
- To investigate the association between Hh pathway activation and CC patient outcomes.
- To determine the functional role of Hh signaling in CC cell proliferation, migration, and invasion.
- To explore the therapeutic potential of Hh pathway inhibition in CC.
Main Methods:
- Gene expression analysis of Hh target genes (GLI1, GLI2) in a cohort of 382 CC patients.
- Pharmacological inhibition of Smoothened (SMO) using GDC-0449 in CC cell lines (HCT 116, SW480, SW620).
- Genetic silencing of SMO and treatment with a Sonic Hedgehog-specific monoclonal antibody (5E1).
Main Results:
- Increased GLI1 expression in CC patients was significantly associated with reduced survival.
- GDC-0449 treatment reduced Hh target gene expression, cell proliferation, migration, and invasion in CC cell lines.
- SMO inhibition led to p21 upregulation, Cyclin D1 downregulation, Snail1 downregulation, and induction of epithelial markers (Cytokeratin-18, E-cadherin).
- Genetic SMO silencing and 5E1 treatment confirmed these findings, suggesting an Hh autocrine loop.
Conclusions:
- The Hedgehog pathway is constitutively active in CC cell lines and contributes to tumor progression.
- Inhibition of SMO effectively suppresses key oncogenic processes in CC cells, including proliferation and invasion.
- Targeting the Hh pathway, particularly SMO, represents a promising therapeutic strategy for colorectal cancer.
Related Concept Videos
Feedback Inhibition
Plasticity
Plasticizers
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
Plastic Behavior
Plastic Deformations
Plastic Deformations

